Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Investigation on the Cortical Communication (CortiCom) System

NCT: NCT03567213 · RECRUITING

NCT IDNCT03567213
StatusRECRUITING
Start Date2021-12-14
Completion2030-12-31
SponsorJohns Hopkins University (OTHER)
First posted
Last updated

Brief Summary

The CortiCom system consists of 510(k)-cleared components: platinum PMT subdural cortical electrode grids, a Blackrock Microsystems patient pedestal, and an external NeuroPort Neural Signal Processor. Up to two grids will be implanted in the brain, for a total channel count of up to 128 channels, for six months. In each participant, the grid(s) will be implanted over areas of cortex that encode speech and upper extremity movement.

Frequently Asked Questions

What is Investigation on the Cortical Communication (CortiCom) System?

Investigation on the Cortical Communication (CortiCom) System is a clinical trial registered under NCT03567213. Current status: RECRUITING.

What is the status of NCT03567213?

The current status of NCT03567213 (Investigation on the Cortical Communication (CortiCom) System) is: RECRUITING.

When did Investigation on the Cortical Communication (CortiCom) System start?

Investigation on the Cortical Communication (CortiCom) System started on 2021-12-14.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.